Cargando…
An opportunity to increase human papillomavirus vaccination rates: Change the guidelines
Given the low rates of Human Papillomavirus (HPV) vaccination initiation and timely series completion in 11- and 12-year old children, we sought to assess potential opportunities for initiating routine vaccination at a younger age. A cross-sectional study of Latino parents of HPV vaccine-eligible 9-...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746429/ https://www.ncbi.nlm.nih.gov/pubmed/36282533 http://dx.doi.org/10.1080/21645515.2022.2136444 |
_version_ | 1784849357529415680 |
---|---|
author | Aragones, Abraham Gany, Francesca Kaplan, Andrea Bruno, Denise |
author_facet | Aragones, Abraham Gany, Francesca Kaplan, Andrea Bruno, Denise |
author_sort | Aragones, Abraham |
collection | PubMed |
description | Given the low rates of Human Papillomavirus (HPV) vaccination initiation and timely series completion in 11- and 12-year old children, we sought to assess potential opportunities for initiating routine vaccination at a younger age. A cross-sectional study of Latino parents of HPV vaccine-eligible 9- or 10-year–old children in New York City assessed whether there were opportunities to discuss the HPV vaccine during their most recent primary care provider (PCP) visit. Parents were approached between November, 2016 and January, 2018. Of 86 parents who participated, 97% reported having visited the child’s PCP in the previous year for an annual checkup and 85% reported that they had neither discussed the HPV vaccine nor received a recommendation for the vaccine during that visit. In a population of Latino parents, predominantly Mexican immigrants with less than a high school education and limited English proficiency, most 9- to 10-year–old children followed the recommendation for an annual PCP visit. Lowering the recommended age for routine vaccination with the HPV vaccine to 9 − 10 years of age should be considered as an important strategy to increase HPV vaccination rates in this and other populations. |
format | Online Article Text |
id | pubmed-9746429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-97464292022-12-14 An opportunity to increase human papillomavirus vaccination rates: Change the guidelines Aragones, Abraham Gany, Francesca Kaplan, Andrea Bruno, Denise Hum Vaccin Immunother HPV – Research Article Given the low rates of Human Papillomavirus (HPV) vaccination initiation and timely series completion in 11- and 12-year old children, we sought to assess potential opportunities for initiating routine vaccination at a younger age. A cross-sectional study of Latino parents of HPV vaccine-eligible 9- or 10-year–old children in New York City assessed whether there were opportunities to discuss the HPV vaccine during their most recent primary care provider (PCP) visit. Parents were approached between November, 2016 and January, 2018. Of 86 parents who participated, 97% reported having visited the child’s PCP in the previous year for an annual checkup and 85% reported that they had neither discussed the HPV vaccine nor received a recommendation for the vaccine during that visit. In a population of Latino parents, predominantly Mexican immigrants with less than a high school education and limited English proficiency, most 9- to 10-year–old children followed the recommendation for an annual PCP visit. Lowering the recommended age for routine vaccination with the HPV vaccine to 9 − 10 years of age should be considered as an important strategy to increase HPV vaccination rates in this and other populations. Taylor & Francis 2022-10-25 /pmc/articles/PMC9746429/ /pubmed/36282533 http://dx.doi.org/10.1080/21645515.2022.2136444 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | HPV – Research Article Aragones, Abraham Gany, Francesca Kaplan, Andrea Bruno, Denise An opportunity to increase human papillomavirus vaccination rates: Change the guidelines |
title | An opportunity to increase human papillomavirus vaccination rates: Change the guidelines |
title_full | An opportunity to increase human papillomavirus vaccination rates: Change the guidelines |
title_fullStr | An opportunity to increase human papillomavirus vaccination rates: Change the guidelines |
title_full_unstemmed | An opportunity to increase human papillomavirus vaccination rates: Change the guidelines |
title_short | An opportunity to increase human papillomavirus vaccination rates: Change the guidelines |
title_sort | opportunity to increase human papillomavirus vaccination rates: change the guidelines |
topic | HPV – Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746429/ https://www.ncbi.nlm.nih.gov/pubmed/36282533 http://dx.doi.org/10.1080/21645515.2022.2136444 |
work_keys_str_mv | AT aragonesabraham anopportunitytoincreasehumanpapillomavirusvaccinationrateschangetheguidelines AT ganyfrancesca anopportunitytoincreasehumanpapillomavirusvaccinationrateschangetheguidelines AT kaplanandrea anopportunitytoincreasehumanpapillomavirusvaccinationrateschangetheguidelines AT brunodenise anopportunitytoincreasehumanpapillomavirusvaccinationrateschangetheguidelines AT aragonesabraham opportunitytoincreasehumanpapillomavirusvaccinationrateschangetheguidelines AT ganyfrancesca opportunitytoincreasehumanpapillomavirusvaccinationrateschangetheguidelines AT kaplanandrea opportunitytoincreasehumanpapillomavirusvaccinationrateschangetheguidelines AT brunodenise opportunitytoincreasehumanpapillomavirusvaccinationrateschangetheguidelines |